Significant anti-proliferative effects across all MM cell lines were observed for inhibitors targeting ProRS (NCP26, HFG, ProSA), ThrRS (borrelidin) and CysRS (CysSA) (Fig. 1G). This evidence concerns the gene PARS2 and Miyoshi myopathy.